In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Cardiovascular imaging: a logistic and futuristic approach, ESC and the Interamerican Society of Cardiology

ESC Congress Report

  • 3D transthoracic echo is useful in the evaluation of LV volumes and function.
  • Cardiac CT has a role in the assessment of low to moderate risk patients with uncertain chest pain origin.
  • Cardiac MRI is very useful in tissue characterization and detection of myocardial fibrosis which is  a prognostic tool.
  • Fusion  imaging leads the 3D transesophageal echocardiography to combine with fluoroscopy and may guide the interventional cardiology

View the Slides from this session in ESC Congress 365

In this interesting session, Dr Pedro Guitierrez- Fajardo (Guadalajara, MX) discussed the usefulness of 3D echo today. He believes that 3D echo is very useful in the assessment of Left Ventricular (LV) volumes and function as it appears to have less variability than 2D echo and a close relationship with MRI.
Additionally, he suggests that the estimation of LV synchrony, especially with 3D speckle tracking echocardiography may become a promising tool.
He noted that with a 3D model it is possible to evaluate the right ventricle size and function,  which will  help many patients in the near future.

Cristian Lopez (Santiago, CL) discussed the use of multi-slice CT in cardiology. He focused on coronary angiography (CTA) in symptomatic patients with negative stress tests and uncertain chest pain origin. He also talked about the contribution of CTA in the examination of coronary anatomy, plaque characterization and congenital coronary anomalies. He noted the possible use of Cardiac CT in the evaluation of cardiac anatomy function and in the recognition of cardiac masses.

Sophie Mavrogeni (Athens, GR) focused on how to use cardiac MRI (CMR)  as a pathophysiology tool in the assessment of myocardial inflammation, fibrosis, acuity of heart involvement, tissue characterization and great vessel pathophysiology. She also discussed  how the developmental evolution of CMR can be incorporated into practice.
She supports the CMR use in coronary artery disease for the recognition of silent myocardial infarction, late gadolinium enhancement (LGE) extent, perfusion defects  and atheromatous plaque characterization. In myocarditis, she says that early GE  and LGE had the best correlation for the development of Heart  Failure.
Dr. Mavrogeni emphasized the detection of cardiac involvement with CMR in other internal diseases, such as in hematology (thalasemia, iron overloaded diseases, etc.)  in rheumatology (like rheumatic arthritis  lupus systemic sclerosis, etc ) in  endocrinology  and in oncology. Finally, she mentioned a possible future role of interventional CMR in pediatrics and in electrophysiology.

Eduardo Casas Rojo (Madrid, ES) discussed  fusion imaging  in cardiology. Starting with fusion imaging with PET/SPECT+ CT software (radiation imaging) he moved on to discuss newer fusion with 3D- speckle imaging and cardiac CT at rest, or stress for ischemia detection. Additionally, he noted a different application of hybrid images: the echo navigator. With echo navigator, echo goes into the catherization laboratory and synchronizes fluoroscopy and real-time 3D echo and helps guide interventional techniques, like foramen ovale closure, TAVI, or periprosthetic leaks closure.   




Cardiovascular imaging: a logistic and futuristic approach, ESC and the Interamerican Society of Cardiology

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.